About 1.5% of the overall population suffers from hoarseness; among the most common causes of hoarseness are vocal fold nodules and polyps. Vocal fold nodules and polyps represent reactive changes of the laryngeal mucosa and adjacent stroma that result in benign nodular or polypoid growths. Their etiology is multifactorial, but vocal misuse is one of the most common causes, followed by infection, smoking, and hypothyroidism. Extroverts are more likely to develop nodules and polyps.
The causes of a nodule are slightly different from the causes of a polyp. In children, nodules are slightly more common in boys than in girls; polyps have no predilection for either sex, and they can occur at any age.
Nodules usually affect the anterior to middle thirds of the true vocal folds, and they are nearly always bilateral. In addition to the vocal folds, polyps can affect the aryepiglottic fold, ventricular space, and/or the Reinke space, and they are usually unilateral. Voice reeducation, voice therapy, behavior modification, drug therapy, and surgery all playa role in management. Nodules appear as an edematous, gelatinous, hemorrhagic, firm or fixed mass, while polyps manifest as a solitary, soft, rubbery, translucent to red-raspberry-colored mass. Nodules are usually smaller than 0.3 em, while polyps are usually larger than 0.3 cm.
Histologically, nodules and polyps are indistinguishable. Both exhibit an arc of development. An intact epithelium overlies an edematous stroma, which contains proteinaceous material within the interstitium (figure 1). The vascularized stroma exhibits hemorrhage with a loose myxoid matrix. Inflammation is uncommon, although surface granulation tissue and fibrin may be seen. With time, the myxoid material is replaced by fi- Pregnancy Teratogenic effects; Pregnancy Category C Olopatadinewas found notto beteratogenic inrats and rabbrts. However, rats treated at600 mg/kg/day, or 150,000 times the MROHD and rabbits treated at400 mg/kg/day, orapplUXlmately 100,000 times the MROHD, during organogenesis showed a decrease in live fetuses. Inaddition, rats treated with 600mg/kg/dayofolopatadinedunngorganogeneslsshowedadecreaseinfetalwelght.Further,ratstreated wrth 600 mg/kg/dayofolopatadinedunng lategestation through the lactatIOn period showed adecrease in neonatal survival and body weight. There are, however, no adequate and well-controlled studies In pregnant women. Because animal studies are not always predlclive ofhuman responses, this drug should be used inpregnant women only ifthe potential benefrt tothe mother justfles the potenlial risk tothe embryo orfetus.
Nursing Mothers
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Pediatric Use Safety and effectiveness inpediatric patients below the age of2years have not been established.
Geriatric Use
No overall differences in safety and effectiveness have been observed between elderly and younger patients.
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Polyps are separated into four types: edematous, vascular, myxoid, and hyaline, based on the stage of development at the time the sample was obtained and on the dominant histologic pattern (figure 2). The primary differential diagnoses include amyloid, myxoma, spindle cell (sarcomatoid) squamous cell carcinoma, and contact ulcer. 
